Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Tetraphase Pharmaceuticals Company Profile (NASDAQ:TTPH)

Consensus Ratings for Tetraphase Pharmaceuticals (NASDAQ:TTPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.92)
Consensus Price Target: $37.98 (1.34% upside)

Analysts' Ratings History for Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/18/2014Robert W. BairdReiterated RatingBuy$41.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014WedbushReiterated RatingBuy$51.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Needham & Company LLCBoost Price TargetBuy$28.00 -> $46.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Cantor FitzgeraldBoost Price TargetBUY$26.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Stifel NicolausBoost Price TargetBuy$28.00 -> $54.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014GuggenheimBoost Price Target$45.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Brean CapitalBoost Price TargetBuy$23.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
11/17/2014ZacksUpgradeNeutral -> Outperform$25.80ViewTweet This Rating  Share This Rating on StockTwits
11/4/2014WedbushInitiated CoverageOutperform$31.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2014Needham & Company LLCBoost Price TargetBuy$17.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2014Stifel NicolausBoost Price TargetBuy$21.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2014JMP SecuritiesBoost Price TargetOutperform$20.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
9/8/2014Cantor FitzgeraldInitiated CoverageBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
9/3/2014JMP SecuritiesBoost Price TargetOutperform$16.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2014Brean CapitalInitiated CoverageBuy$23.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2014TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
6/20/2014GabelliInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
6/16/2014Robert W. BairdInitiated CoverageOutperform$21.00ViewTweet This Rating  Share This Rating on StockTwits
6/2/2014WBB SecuritiesUpgradeSpeculative Buy -> Buy$13.50 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/3/2014Brean CapitalInitiated CoverageBuy$23.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014Needham & Company LLCBoost Price TargetBuy$15.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysBoost Price TargetOverweight$16.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013GuggenheimInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
10/2/2013Ladenburg ThalmannBoost Price TargetBuy$13.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013JMP SecuritiesBoost Price TargetMarket Outperform$12.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013Needham & Company LLCReiterated RatingBuy$12.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013WBB SecuritiesInitiated CoverageSpeculative BuyViewTweet This Rating  Share This Rating on StockTwits
8/21/2013Ladenburg ThalmannInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013JMP SecuritiesInitiated CoverageOutperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013BMO Capital MarketsInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
4/15/2013Stifel NicolausInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013BarclaysInitiated CoverageOverweight$16.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013Needham & Company LLCInitiated CoverageBuy$12.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/19/2012 forward)